OGI
Organigram Global, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.05
−1.87%Forward multiples
Based on analyst estimates
- P/E forward
- 43.02x
- P/E 2026E
- 3.18x
- P/E 2027E
- 48.94x
- P/E 2028E
- 22.02x
- P/S forward
- 0.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.32x
- PEG TTM
- —
- Price / book
- 0.38x
- Price / sales
- 0.68x
- Price / cash flow
- -7.42x
Enterprise value
- Enterprise value
- $208.8M
- EV / sales
- 0.94x
- EV / EBITDA
- 15.31x
- EV / EBIT
- -43.65x
- Market cap
- $151.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026